研究铁调节性红状腺因子在 β-thalassemia 的儿童
Yaxuan Cao1, Ken Huang2, Jianming Luo1
1Department of Pediatrics, The First Affiliated Hospital Of Guangxi Medical University, Nanning, Guangxi, China.
概括
在患有β-thalassemia major (β-TM) 的儿童中,FAM210B和NCOA4的mRNA水平在血红蛋白较低的儿童中较高,这表明红色素形成和贫血严重程度的潜在作用.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 大型β-thalassemia (β-TM) 是一种严重的遗传性血液疾病,需要终身输血治疗.
- 铁的调节和红质形成对于管理β-TM至关重要.
- 在β-TM病理生理学中的新型红状腺因子的作用需要阐明.
研究的目的:
- 为了比较mRNA表达的铁调节性红色球因子在儿童β-TM.
- 研究这些因素与输血要求之间的关系.
- 确定β-TM中贫血严重程度的潜在生物标志物.
主要方法:
- 招募了98名患有输血依赖β-TM的儿童.
- 根据血红蛋白水平 (≤90 g/L与>90 g/L) 分类儿童.
- 使用实时光定量PCR测量FAM210B,CCD115,HO-1,PCBP1,PCBP2,NCOA4和Nrf2.2的mRNA表达.
主要成果:
- 在低血红蛋白组 (p<0.05) 中,FAM210B,HO-1和NCOA4的mRNA水平显著更高.
- 增加的FAM210B和NCOA4表达与增加的输血需求相关.
- 对于CCDC115,PCBP1,PCBP2和Nrf2.2没有发现显著差异.
结论:
- FAM210B和NCOA4可以作为儿科β-TM中红色素形成和贫血严重性的指标.
- 这些因素需要进一步研究,作为β-TM和相关疾病的潜在治疗点.
关键词:
Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb Hb H1 H1 H2 H1 H3 H1 H1 H1 H2 H1 H3 H1 H1 H1 H2 H1 H3 H1 H1 H1 H1 H2 H3 H1 H1 H1 H1铁的调节性红细胞因子输血疗法是一种输血疗法.在 β-TM 中.更多相关视频
12:44Electrophoretic Mobility Shift Assay EMSA for the Study of RNA-Protein Interactions: The IRE/IRP Example
Published on: December 3, 2014
53.7K
06:40Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
Published on: September 9, 2014
15.0K
相关概念视频
Factors Affecting Erythropoiesis
3.2K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.2K
Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Disorders of Erythrocytes
903
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
903
Transcription Factors
75.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.7K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
